Jennifer Juno
@jenjuno.viralvaxlab.com
🇨🇦 in 🇦🇺 Scientist. Geek. Feminist. She/her. Lab head (viralvaxlab.com) at the Doherty Institute and University of Melbourne, interested in all things CD4/TFH/vaccine and virus-related. I stare at dots a lot.
Reposted by Jennifer Juno
I am always so impressed by @marioskoutsakos.viralvaxlab.com’s elegant work on influenza B virus vaccines. Congratulations, Marios, on your Early Career Researcher Award! #19vaccinecongress
September 8, 2025 at 2:38 AM
I am always so impressed by @marioskoutsakos.viralvaxlab.com’s elegant work on influenza B virus vaccines. Congratulations, Marios, on your Early Career Researcher Award! #19vaccinecongress
Reposted by Jennifer Juno
The Precision Immunology and Immune Biotherapies Programs at the Garvan Institute are looking for new Faculty members. Come join us and work with amazing scientists in an amazing place @labphan.bsky.social @garvaninstitute.bsky.social
www.nature.com/naturecareer...
www.nature.com/naturecareer...
Garvan Faculty Member - Sydney (LGA), New South Wales (AU) job with The Garvan Institute | 12841341
The Garvan Institute invites applicants for Faculty-level positions in the Immune Biotherapies and Precision Immunology Programs.
www.nature.com
July 9, 2025 at 11:52 PM
The Precision Immunology and Immune Biotherapies Programs at the Garvan Institute are looking for new Faculty members. Come join us and work with amazing scientists in an amazing place @labphan.bsky.social @garvaninstitute.bsky.social
www.nature.com/naturecareer...
www.nature.com/naturecareer...
Reposted by Jennifer Juno
Publication alert: "No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations" @natcomms.nature.com The backstory is particularly interesting-it's a tale of the conflicting needs of scientists & decision makers in times of disinformation ....1/n
No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations
Nature Communications - Repeated vaccination is needed to maintain high levels of SARS-CoV-2 immunity in vulnerable populations, but there is concern that it could lead to immune exhaustion. Here,...
rdcu.be
June 6, 2025 at 7:04 PM
Publication alert: "No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations" @natcomms.nature.com The backstory is particularly interesting-it's a tale of the conflicting needs of scientists & decision makers in times of disinformation ....1/n
Reposted by Jennifer Juno
Excited to have our latest research published in @jem.org this week and also highlighted by @natrevimmunol.nature.com
@wehi-research.bsky.social @benjbroom.bsky.social
@wehi-research.bsky.social @benjbroom.bsky.social
May 8, 2025 at 11:31 PM
Excited to have our latest research published in @jem.org this week and also highlighted by @natrevimmunol.nature.com
@wehi-research.bsky.social @benjbroom.bsky.social
@wehi-research.bsky.social @benjbroom.bsky.social
Fantastic work from @labphan.bsky.social and @mlmunier.bsky.social combining mouse models and clinical studies to understand B cell recall following booster vaccination. Check out the paper and thread below! ⤵️
Happy #DayofImmunology! Congrats @ramadhenni.bsky.social & Alexandra Carey Hoppé it's out (finally!) @cp-cell.bsky.social! Incredibly grateful to co-leads @mlmunier.bsky.social, Vanessa Venturi & Tony Kelleher & all brilliant folks @garvaninstitute.bsky.social & Kirby Inst. for fantastic collab! 🧵
Macrophages direct location-dependent recall of B cell memory to vaccination
Vaccines generate long-lived plasma cells and memory B cells (Bmems) that may re-enter secondary germinal centers (GCs) to further mutate their B cell…
www.sciencedirect.com
April 29, 2025 at 1:50 PM
Fantastic work from @labphan.bsky.social and @mlmunier.bsky.social combining mouse models and clinical studies to understand B cell recall following booster vaccination. Check out the paper and thread below! ⤵️
Happy to report that Mitchell's paper on CD4 T cells and AIM assays is now available online at Science Advances!
www.science.org/doi/10.1126/...
Thanks to all our collaborators in @viralvaxlab.bsky.social and @thedohertyinst.bsky.social, including @assocprofashhaque.bsky.social lab
www.science.org/doi/10.1126/...
Thanks to all our collaborators in @viralvaxlab.bsky.social and @thedohertyinst.bsky.social, including @assocprofashhaque.bsky.social lab
April 27, 2025 at 5:07 PM
Happy to report that Mitchell's paper on CD4 T cells and AIM assays is now available online at Science Advances!
www.science.org/doi/10.1126/...
Thanks to all our collaborators in @viralvaxlab.bsky.social and @thedohertyinst.bsky.social, including @assocprofashhaque.bsky.social lab
www.science.org/doi/10.1126/...
Thanks to all our collaborators in @viralvaxlab.bsky.social and @thedohertyinst.bsky.social, including @assocprofashhaque.bsky.social lab
Check out the latest from @viralvaxlab.bsky.social postdoc Wen Shi Lee, developing monoclonal antibodies that neutralise the NL63 coronavirus!
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
www.nature.com/articles/s44...
www.nature.com/articles/s44...
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus - npj Viruses
npj Viruses - Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
www.nature.com
April 25, 2025 at 11:54 PM
Check out the latest from @viralvaxlab.bsky.social postdoc Wen Shi Lee, developing monoclonal antibodies that neutralise the NL63 coronavirus!
Great new story exploring how B cells can recognise glycans (and still get T cell help!) from @precisionvaxlab.bsky.social and team!
New preprint alert 🚨
My team and I are pleased to share our most recent story about how bacterial pathogen (Streptococcus pyogenes, Strep A) exposure induces antibody responses against glycan and protein antigens.
For paper: SSRN ssrn.com/abstract=519...
biorxiv : doi: doi.org/10.1101/2025...
My team and I are pleased to share our most recent story about how bacterial pathogen (Streptococcus pyogenes, Strep A) exposure induces antibody responses against glycan and protein antigens.
For paper: SSRN ssrn.com/abstract=519...
biorxiv : doi: doi.org/10.1101/2025...
April 4, 2025 at 4:44 AM
Great new story exploring how B cells can recognise glycans (and still get T cell help!) from @precisionvaxlab.bsky.social and team!
Reposted by Jennifer Juno
New research in @jimmunol.bsky.social from @jenjuno.viralvaxlab.com and Dr. Hyon-Xhi Tan suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development. Learn more: news.aai.org/2025/03/10/m.... #medsky #immunosky #idsky
Multi-Dose Vaccines Administered in the Same Site Boost Immune Response - AAI News
New research suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development.
news.aai.org
March 13, 2025 at 10:44 AM
New research in @jimmunol.bsky.social from @jenjuno.viralvaxlab.com and Dr. Hyon-Xhi Tan suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development. Learn more: news.aai.org/2025/03/10/m.... #medsky #immunosky #idsky
Check out the latest work from @viralvaxlab.bsky.social, now online in @jimmunol.bsky.social!
New research from @thedohertyinst.bsky.social suggests that receiving multiple doses of a vaccine in the same limb leads to faster antibody development, an important strategy for providing #immunity quickly during a pandemic or disease #outbreak. #ReadTheJI #immunology
ow.ly/c28N50VeRGR
ow.ly/c28N50VeRGR
Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2
Abstract. Human clinical trials have reported immunological outcomes can differ between ipsilateral (same side) and contralateral (alternate sides) prime-b
ow.ly
March 11, 2025 at 9:04 AM
Check out the latest work from @viralvaxlab.bsky.social, now online in @jimmunol.bsky.social!
Reposted by Jennifer Juno
Should you get the COVID mRNA and flu vaccines in the same or opposite arms?
Randomised trial by Lee, Selva, et al. suggests it is preferable to administer the vaccines at different sites. buff.ly/3D4gX95
Randomised trial by Lee, Selva, et al. suggests it is preferable to administer the vaccines at different sites. buff.ly/3D4gX95
February 28, 2025 at 4:13 PM
Should you get the COVID mRNA and flu vaccines in the same or opposite arms?
Randomised trial by Lee, Selva, et al. suggests it is preferable to administer the vaccines at different sites. buff.ly/3D4gX95
Randomised trial by Lee, Selva, et al. suggests it is preferable to administer the vaccines at different sites. buff.ly/3D4gX95
Reposted by Jennifer Juno
If any American immunologists want to write an op-ed for @immunolcellbiol.bsky.social on the impact of the new executive orders, please contact me
February 3, 2025 at 10:05 AM
If any American immunologists want to write an op-ed for @immunolcellbiol.bsky.social on the impact of the new executive orders, please contact me
Reposted by Jennifer Juno
Kicking off the new year searching for a postdoc to join our team @wehi-research.bsky.social
Apply now and spread the word
Apply now and spread the word
Research Officer
Job Title Research Officer Job Description An excellent opportunity is available for a Research Officer to join the Groom Laboratory in the Immunology Division at Australia’s pre-eminent biomedical re...
wehi.wd3.myworkdayjobs.com
January 15, 2025 at 5:41 AM
Kicking off the new year searching for a postdoc to join our team @wehi-research.bsky.social
Apply now and spread the word
Apply now and spread the word
As a first #ImmunoSky post, I’m excited to share our latest pre-print, by the fantastic Mitchell Zheng!
www.biorxiv.org/content/10.1...
Our group is interested in virus-specific CD4 T cells, which means we often use in vitro stimulations (like the AIM assay) to find our cells of interest. 🧵 1/9
www.biorxiv.org/content/10.1...
Our group is interested in virus-specific CD4 T cells, which means we often use in vitro stimulations (like the AIM assay) to find our cells of interest. 🧵 1/9
www.biorxiv.org
December 20, 2024 at 3:39 AM
As a first #ImmunoSky post, I’m excited to share our latest pre-print, by the fantastic Mitchell Zheng!
www.biorxiv.org/content/10.1...
Our group is interested in virus-specific CD4 T cells, which means we often use in vitro stimulations (like the AIM assay) to find our cells of interest. 🧵 1/9
www.biorxiv.org/content/10.1...
Our group is interested in virus-specific CD4 T cells, which means we often use in vitro stimulations (like the AIM assay) to find our cells of interest. 🧵 1/9
Reposted by Jennifer Juno
Sectarianism in immunology.
(highly specific for immunologists, all credit to @pedromics on X)
1/8
(highly specific for immunologists, all credit to @pedromics on X)
1/8
November 25, 2024 at 7:35 PM
Sectarianism in immunology.
(highly specific for immunologists, all credit to @pedromics on X)
1/8
(highly specific for immunologists, all credit to @pedromics on X)
1/8